By Melesa Freerks, Nathaniel Lacktman, Christopher Donovan, Heidi Jeffery and Paige Papandrea (July 13, 2018, 1:50 PM EDT) -- This article assesses the characteristics of the digital health industry and examines whether the market is ripe for notable private equity investment. The broad scope of digital health includes categories such as mobile health (mHealth), health information technology, wearable devices, telehealth and telemedicine, and personalized medicine. After several years of exponential growth, the telemedicine and digital health industry has reached an inflection point — moving from infancy to adolescence — as consumer-oriented digital health care solutions gain popularity, and traditional health care providers turn to virtual care. Naturally, investment in digital health companies has seen a corresponding increase, primarily led by venture capital. But with increasing size of venture investments deployed into fewer emerging companies, telemedicine is just now starting to gain the interest of private equity. Moreover, a handful of notable mergers could signal more industry consolidation, another sign of market maturation in this still nascent industry. Clearly, many health care institutions are investing in telemedicine and digital health (including via their own venture funds), if only to remain competitive. What is it that has venture capital, private equity and other players so interested in digital health? And what are the key legal considerations an investor should note when evaluating a telemedicine or digital health investment?...